Optimising Treatment
The consortium has published guidance on how to optimise and implement a synergistic medical and surgical treatment plan for perianal Crohn's disease. This involved the input of a large international panel of medical & surgical perianal disease experts.
Included in the guidance are:
When a fistula may be suitable for surgical repair - and how medications improving perianal inflammation can assist in promoting the best post-operative outcomes.
How medications & surgeries may be utilised for targeting both symptomatic improvements and fistula healing in pCD
How to optimise medications and manage them around the time of surgeries
How medical & surgical care can be coordinated to "downstage" fistula classification groups - i.e. simplifying a non-repairable fistula (2b) where possible into a repairable (2a) one.
Figure: A case of anatomical rationalization and fistula downstaging from Class 2b to 2a. (A), Active intersphincteric horseshoe extension at presentation; (B), Healed (fibrosed) horseshoe following intensive VAAFT; (C), Main fistula tract at presentation; (D), Main tract with reduced but ongoing activity following VAAFT; (E), Radiological healing (fibrosis) of main tract following definitive surgical repair.
Related Researchers
City: Liège | Country: Belgium
Consortium description coming soon.
City: London | Country: United Kingdom
The Fistula Research Unit at St. Mark’s Hospital is headed by Professor Ailsa Hart and Mr Phil Tozer. The centre has a strong history of championing research in the field of perianal Crohn’s Disease and progressing the medical and surgical management of perianal fistula.
City: Barcelona | Country: Spain
The IBD Research Group at IDIBAPS, Hospital Clinic in Barcelona, is a multidisciplinary unit involving translational and clinical researchers investigating the molecular and cellular mechanisms involved in the development of IBDs, particularly difficult-to-treat complications, including fibrosis and perianal fistulizing disease.
City: Madrid | Country: Spain
Hospital Universitario 12 de Octubre, located in Madrid, is one of the largest and most prestigious tertiary care hospitals in Spain. As a major academic centre affiliated with Universidad Complutense de Madrid, it provides highly specialised care and serves a large population from …
City: Chicago | Country: U.S.A
Consortium description coming soon
City: Vancouver | Country: Canada
Astrid Williams has joined the team at the IBD centre of B in 2024. From 2018 to 2023, she was a Staff Specialist Gastroenterologist at Liverpool Hospital in Sydney, Australia.
City: Cambridge | Country: United Kingdom
Dr Nuru Noor is a Clinical Lecturer in Gastroenterology based at the University of Cambridge in the UK. He also works as an Honorary Postdoctoral Research Associate at the Medical Research Council Clinical Trials Unit
City: Abu Dhabi | Country: United Arab Emirates
Dr. Sara El Ouali is a consultant gastroenterologist at Cleveland Clinic Abu Dhabi (CCAD) and is an Assistant Professor of Medicine at the Cleveland Clinic Lerner College of Medicine in Cleveland, Ohio …
City: London | Country: United Kingdom
The Fistula Research Group at the University of Nottingham and Motilent is at the forefront of research in perianal Crohn’s disease and Inflammatory Bowel Disease.
City: Paris | Country: France
The Proctology Department at Hôpital Paris Saint-Joseph is a department specialising in the medical, instrumental and surgical treatment of diseases of the anus.
City: Ghent | Country: Belgium
The IBD unit at the University Hospital of Ghent is headed by prof. dr. Triana Lobaton together with dr. Jeroen Geldof. Multidisciplinary, patient-focussed treatment of IBD with attention for extraintestinal manifestations and holistic management has been the motto of the team for over several decades.
City: New York | Country: U.S.A
The perianal fistulizing Crohn’s disease clinical and research program at The Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center at Mount Sinai is co-led by gastroenterologist Dr. Serre-Yu Wong and colorectal surgeon Dr Sergey Khaitov.
City: Leuven | Country: Belgium
The perianal Fistula Research Program within the IBD referral centre of UZ/KU Leuven is coordinated by colorectal surgeons Gabriele Bislenghi and André D’Hoore and gastroenterologists Séverine Vermeire and Bram Verstockt.
City: Washington I Country: U.S.A
The IBD-Radiology Collaborative group at Washington University School of Medicine in St. Louis is headed by (left to right) Siyan ‘Stewart’ Cao MD, PhD, Parakkal Deepak, MBBS, MS and David H. Ballard, MD. The group is conducting basic, translational and clinical research in the field of perianal Crohn’s Disease from bedside to scanner and bench and back to bedside.
City: Melbourne | Country: Australia
The St Vincent's Hospital Melbourne Fistula Research Group is a passionate team of Australian researchers based in Melbourne, focused on expanding current and future research in the area of perianal fistulising Crohn’s disease. Our expert research team includes colorectal surgeon Dr. Cori Behrenbruch and Mr Michael Johnston, radiologist Dr. Leon Winata, gastroenterologists A/Prof John Ding and Dr. Michael De Gregorio, and research fellow Dr. Imogen Hartley and Dr Nicholas Clark.
City: San Diego | Country: U.S.A
Led by Dr. Amy Lightner, a colorectal surgeon and Professor of Molecular and Cellular Biology and Professor of Immunology, the Lightner Lab at Scripps Research is dedicated to pioneering research in inflammatory bowel disease (IBD) and advancing novel treatment strategies for both complex luminal disease and perianal fistulizing disease…
City: Sāo Paulo | Country: Brazil
The IBD unit at the Santa Cruz Hospital, led by Prof. Dr. Natália Queiroz, is a recently established team, just three years old. Despite being a young unit, we are committed to providing multidisciplinary care with a patient-centered approach to treating IBD
Publications and Articles
A global TOpClass review and expert consensus outlining the small but significant risk of anorectal and fistula-associated cancers in long-standing perianal Crohn’s disease, with practical guidance on risk awareness and prompt investigation of new or changing perianal symptoms.